CA2007699A1 - Introns et exons du gene de la fibrose kystique et une mutation a 1507 du gene - Google Patents

Introns et exons du gene de la fibrose kystique et une mutation a 1507 du gene

Info

Publication number: CA2007699A1
Authority: CA; Canada
Prior art keywords: dna; gene; sequence; mutant; protein
Prior art date: 1990-01-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2007699

Other languages

English (en)

Inventor

Lap-Chee Tsui

Johanna M. Rommers

Bat-Sheva Kerem

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hsc Research Development Corp

Original Assignee

Hsc Research Development Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-01-12

Filing date

1990-01-12

Publication date

1991-07-12

1990-01-12 Application filed by Hsc Research Development Corp filed Critical Hsc Research Development Corp

1990-01-12 Priority to CA 2007699 priority Critical patent/CA2007699A1/fr

1991-01-11 Priority to DE69132616T priority patent/DE69132616T2/de

1991-01-11 Priority to CA002073441A priority patent/CA2073441C/fr

1991-01-11 Priority to US07/890,609 priority patent/US6001588A/en

1991-01-11 Priority to AU70605/91A priority patent/AU7060591A/en

1991-01-11 Priority to EP91902210A priority patent/EP0667900B1/fr

1991-01-11 Priority to PCT/CA1991/000009 priority patent/WO1991010734A1/fr

1991-07-12 Publication of CA2007699A1 publication Critical patent/CA2007699A1/fr

1995-06-06 Priority to US08/469,461 priority patent/US5981178A/en

Status Abandoned legal-status Critical Current

Links

201000003883 Cystic fibrosis Diseases 0.000 title claims abstract description 320
108090000623 proteins and genes Proteins 0.000 title claims abstract description 319
230000035772 mutation Effects 0.000 title claims description 78
108700024394 Exon Proteins 0.000 title description 34
108091092195 Intron Proteins 0.000 title description 13
238000012216 screening Methods 0.000 claims abstract description 35
241001465754 Metazoa Species 0.000 claims abstract description 19
238000004519 manufacturing process Methods 0.000 claims abstract description 9
108020004414 DNA Proteins 0.000 claims description 165
108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 claims description 147
102000012605 Cystic Fibrosis Transmembrane Conductance Regulator Human genes 0.000 claims description 147
210000004027 cell Anatomy 0.000 claims description 109
108091028043 Nucleic acid sequence Proteins 0.000 claims description 103
239000002299 complementary DNA Substances 0.000 claims description 101
238000000034 method Methods 0.000 claims description 99
238000009396 hybridization Methods 0.000 claims description 75
239000002773 nucleotide Substances 0.000 claims description 68
125000003729 nucleotide group Chemical group 0.000 claims description 68
238000012217 deletion Methods 0.000 claims description 64
230000037430 deletion Effects 0.000 claims description 64
238000003752 polymerase chain reaction Methods 0.000 claims description 63
239000000523 sample Substances 0.000 claims description 59
239000012634 fragment Substances 0.000 claims description 57
108090000765 processed proteins & peptides Proteins 0.000 claims description 50
102000004196 processed proteins & peptides Human genes 0.000 claims description 44
230000014509 gene expression Effects 0.000 claims description 42
241000282414 Homo sapiens Species 0.000 claims description 41
229920001184 polypeptide Polymers 0.000 claims description 39
239000013598 vector Substances 0.000 claims description 37
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 36
239000000499 gel Substances 0.000 claims description 28
238000003556 assay Methods 0.000 claims description 23
150000001413 amino acids Chemical group 0.000 claims description 22
210000001519 tissue Anatomy 0.000 claims description 22
238000001514 detection method Methods 0.000 claims description 20
210000002919 epithelial cell Anatomy 0.000 claims description 19
230000000694 effects Effects 0.000 claims description 18
239000003153 chemical reaction reagent Substances 0.000 claims description 15
102000053602 DNA Human genes 0.000 claims description 14
102000004190 Enzymes Human genes 0.000 claims description 14
108090000790 Enzymes Proteins 0.000 claims description 14
125000000539 amino acid group Chemical group 0.000 claims description 14
241000700605 Viruses Species 0.000 claims description 12
239000000203 mixture Substances 0.000 claims description 10
241000588724 Escherichia coli Species 0.000 claims description 9
108020005187 Oligonucleotide Probes Proteins 0.000 claims description 9
239000002751 oligonucleotide probe Substances 0.000 claims description 9
239000003298 DNA probe Substances 0.000 claims description 8
239000012472 biological sample Substances 0.000 claims description 8
210000003754 fetus Anatomy 0.000 claims description 8
210000003917 human chromosome Anatomy 0.000 claims description 8
229960000310 isoleucine Drugs 0.000 claims description 8
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 8
239000000126 substance Substances 0.000 claims description 8
208000024891 symptom Diseases 0.000 claims description 8
239000003155 DNA primer Substances 0.000 claims description 7
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
238000003018 immunoassay Methods 0.000 claims description 7
230000008569 process Effects 0.000 claims description 7
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 6
108020004711 Nucleic Acid Probes Proteins 0.000 claims description 6
239000002853 nucleic acid probe Substances 0.000 claims description 6
241000894006 Bacteria Species 0.000 claims description 5
108020004511 Recombinant DNA Proteins 0.000 claims description 5
239000013599 cloning vector Substances 0.000 claims description 5
229920002401 polyacrylamide Polymers 0.000 claims description 5
102000001253 Protein Kinase Human genes 0.000 claims description 4
210000003527 eukaryotic cell Anatomy 0.000 claims description 4
108060006633 protein kinase Proteins 0.000 claims description 4
241001430294 unidentified retrovirus Species 0.000 claims description 4
241000233866 Fungi Species 0.000 claims description 3
108091027305 Heteroduplex Proteins 0.000 claims description 3
108090000144 Human Proteins Proteins 0.000 claims description 3
102000003839 Human Proteins Human genes 0.000 claims description 3
210000001236 prokaryotic cell Anatomy 0.000 claims description 3
241000701161 unidentified adenovirus Species 0.000 claims description 3
241000701447 unidentified baculovirus Species 0.000 claims description 3
GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 claims description 2
OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 claims description 2
102000013563 Acid Phosphatase Human genes 0.000 claims description 2
108010051457 Acid Phosphatase Proteins 0.000 claims description 2
244000063299 Bacillus subtilis Species 0.000 claims description 2
235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
101710132601 Capsid protein Proteins 0.000 claims description 2
101710094648 Coat protein Proteins 0.000 claims description 2
241000701959 Escherichia virus Lambda Species 0.000 claims description 2
108700039691 Genetic Promoter Regions Proteins 0.000 claims description 2
241000193385 Geobacillus stearothermophilus Species 0.000 claims description 2
102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 2
241000238631 Hexapoda Species 0.000 claims description 2
101710125418 Major capsid protein Proteins 0.000 claims description 2
101710141454 Nucleoprotein Proteins 0.000 claims description 2
101710083689 Probable capsid protein Proteins 0.000 claims description 2
241000589516 Pseudomonas Species 0.000 claims description 2
230000000295 complement effect Effects 0.000 claims description 2
238000012258 culturing Methods 0.000 claims description 2
230000002255 enzymatic effect Effects 0.000 claims description 2
230000002349 favourable effect Effects 0.000 claims description 2
238000010324 immunological assay Methods 0.000 claims description 2
238000010647 peptide synthesis reaction Methods 0.000 claims description 2
230000005258 radioactive decay Effects 0.000 claims description 2
108020003215 DNA Probes Proteins 0.000 claims 4
241000124008 Mammalia Species 0.000 claims 2
241000283984 Rodentia Species 0.000 claims 2
206010052656 Cystic fibrosis carrier Diseases 0.000 claims 1
230000001747 exhibiting effect Effects 0.000 claims 1
238000001917 fluorescence detection Methods 0.000 claims 1
238000003127 radioimmunoassay Methods 0.000 claims 1
238000011830 transgenic mouse model Methods 0.000 claims 1
210000004291 uterus Anatomy 0.000 claims 1
102000004169 proteins and genes Human genes 0.000 abstract description 85
230000002068 genetic effect Effects 0.000 abstract description 22
238000010367 cloning Methods 0.000 abstract description 21
238000003745 diagnosis Methods 0.000 abstract description 13
238000011161 development Methods 0.000 abstract description 5
108020004635 Complementary DNA Proteins 0.000 description 100
238000010804 cDNA synthesis Methods 0.000 description 96
235000018102 proteins Nutrition 0.000 description 80
210000000349 chromosome Anatomy 0.000 description 70
239000000047 product Substances 0.000 description 67
238000004458 analytical method Methods 0.000 description 42
230000000875 corresponding effect Effects 0.000 description 34
230000006870 function Effects 0.000 description 33
239000012528 membrane Substances 0.000 description 32
239000013615 primer Substances 0.000 description 32
108091034117 Oligonucleotide Proteins 0.000 description 30
102000054766 genetic haplotypes Human genes 0.000 description 29
210000004379 membrane Anatomy 0.000 description 28
235000001014 amino acid Nutrition 0.000 description 25
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 25
239000003814 drug Substances 0.000 description 25
201000010099 disease Diseases 0.000 description 22
229940079593 drug Drugs 0.000 description 22
238000002474 experimental method Methods 0.000 description 22
241000699666 Mus <mouse, genus> Species 0.000 description 21
229940024606 amino acid Drugs 0.000 description 21
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
230000009191 jumping Effects 0.000 description 18
238000007894 restriction fragment length polymorphism technique Methods 0.000 description 18
238000012163 sequencing technique Methods 0.000 description 18
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 16
238000013459 approach Methods 0.000 description 16
230000002950 deficient Effects 0.000 description 16
125000003275 alpha amino acid group Chemical group 0.000 description 15
239000000969 carrier Substances 0.000 description 14
108700028369 Alleles Proteins 0.000 description 13
238000006243 chemical reaction Methods 0.000 description 12
230000007547 defect Effects 0.000 description 12
238000013507 mapping Methods 0.000 description 12
239000013612 plasmid Substances 0.000 description 12
238000012360 testing method Methods 0.000 description 12
108700026244 Open Reading Frames Proteins 0.000 description 11
230000003321 amplification Effects 0.000 description 10
238000002955 isolation Methods 0.000 description 10
239000003550 marker Substances 0.000 description 10
238000003199 nucleic acid amplification method Methods 0.000 description 10
210000000106 sweat gland Anatomy 0.000 description 10
238000002560 therapeutic procedure Methods 0.000 description 10
150000002500 ions Chemical class 0.000 description 9
210000000496 pancreas Anatomy 0.000 description 9
108091008146 restriction endonucleases Proteins 0.000 description 9
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 8
108010021466 Mutant Proteins Proteins 0.000 description 8
102000008300 Mutant Proteins Human genes 0.000 description 8
230000004075 alteration Effects 0.000 description 8
238000001502 gel electrophoresis Methods 0.000 description 8
230000006801 homologous recombination Effects 0.000 description 8
238000002744 homologous recombination Methods 0.000 description 8
238000003780 insertion Methods 0.000 description 8
230000037431 insertion Effects 0.000 description 8
210000000287 oocyte Anatomy 0.000 description 8
239000013604 expression vector Substances 0.000 description 7
210000004072 lung Anatomy 0.000 description 7
230000037230 mobility Effects 0.000 description 7
230000036961 partial effect Effects 0.000 description 7
COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 7
238000003906 pulsed field gel electrophoresis Methods 0.000 description 7
238000000746 purification Methods 0.000 description 7
230000006798 recombination Effects 0.000 description 7
238000005215 recombination Methods 0.000 description 7
238000010561 standard procedure Methods 0.000 description 7
230000032258 transport Effects 0.000 description 7
102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 6
206010009944 Colon cancer Diseases 0.000 description 6
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 6
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
239000011543 agarose gel Substances 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
230000002759 chromosomal effect Effects 0.000 description 6
238000001415 gene therapy Methods 0.000 description 6
210000004602 germ cell Anatomy 0.000 description 6
210000004754 hybrid cell Anatomy 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
239000007924 injection Substances 0.000 description 6
238000002347 injection Methods 0.000 description 6
230000037427 ion transport Effects 0.000 description 6
210000004962 mammalian cell Anatomy 0.000 description 6
108020004999 messenger RNA Proteins 0.000 description 6
102000054765 polymorphisms of proteins Human genes 0.000 description 6
230000001105 regulatory effect Effects 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
241000283690 Bos taurus Species 0.000 description 5
108091006146 Channels Proteins 0.000 description 5
108091026890 Coding region Proteins 0.000 description 5
108091035707 Consensus sequence Proteins 0.000 description 5
108091029523 CpG island Proteins 0.000 description 5
238000001712 DNA sequencing Methods 0.000 description 5
241000699670 Mus sp. Species 0.000 description 5
108090000315 Protein Kinase C Proteins 0.000 description 5
102000003923 Protein Kinase C Human genes 0.000 description 5
241000714474 Rous sarcoma virus Species 0.000 description 5
238000002105 Southern blotting Methods 0.000 description 5
238000010171 animal model Methods 0.000 description 5
230000001580 bacterial effect Effects 0.000 description 5
210000004556 brain Anatomy 0.000 description 5
238000002651 drug therapy Methods 0.000 description 5
108020001507 fusion proteins Proteins 0.000 description 5
102000037865 fusion proteins Human genes 0.000 description 5
102000039446 nucleic acids Human genes 0.000 description 5
108020004707 nucleic acids Proteins 0.000 description 5
150000007523 nucleic acids Chemical class 0.000 description 5
230000037361 pathway Effects 0.000 description 5
210000005259 peripheral blood Anatomy 0.000 description 5
239000011886 peripheral blood Substances 0.000 description 5
230000026731 phosphorylation Effects 0.000 description 5
238000006366 phosphorylation reaction Methods 0.000 description 5
230000008707 rearrangement Effects 0.000 description 5
230000001177 retroviral effect Effects 0.000 description 5
239000003981 vehicle Substances 0.000 description 5
102000011045 Chloride Channels Human genes 0.000 description 4
108010062745 Chloride Channels Proteins 0.000 description 4
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
208000026350 Inborn Genetic disease Diseases 0.000 description 4
108090000862 Ion Channels Proteins 0.000 description 4
102000004310 Ion Channels Human genes 0.000 description 4
108010052285 Membrane Proteins Proteins 0.000 description 4
239000004677 Nylon Substances 0.000 description 4
208000035467 Pancreatic insufficiency Diseases 0.000 description 4
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000033228 biological regulation Effects 0.000 description 4
239000000872 buffer Substances 0.000 description 4
210000000170 cell membrane Anatomy 0.000 description 4
230000008859 change Effects 0.000 description 4
230000001086 cytosolic effect Effects 0.000 description 4
235000005911 diet Nutrition 0.000 description 4
230000029087 digestion Effects 0.000 description 4
210000000981 epithelium Anatomy 0.000 description 4
230000001605 fetal effect Effects 0.000 description 4
210000002950 fibroblast Anatomy 0.000 description 4
230000004927 fusion Effects 0.000 description 4
208000016361 genetic disease Diseases 0.000 description 4
210000005260 human cell Anatomy 0.000 description 4
230000002779 inactivation Effects 0.000 description 4
125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 4
229920001778 nylon Polymers 0.000 description 4
238000003793 prenatal diagnosis Methods 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
230000000644 propagated effect Effects 0.000 description 4
238000012552 review Methods 0.000 description 4
238000006467 substitution reaction Methods 0.000 description 4
238000012546 transfer Methods 0.000 description 4
241001515965 unidentified phage Species 0.000 description 4
229920000936 Agarose Polymers 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
241000699800 Cricetinae Species 0.000 description 3
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
102100031780 Endonuclease Human genes 0.000 description 3
102000018697 Membrane Proteins Human genes 0.000 description 3
208000000592 Nasal Polyps Diseases 0.000 description 3
238000012408 PCR amplification Methods 0.000 description 3
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 3
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 3
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
238000012300 Sequence Analysis Methods 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
210000001106 artificial yeast chromosome Anatomy 0.000 description 3
238000000376 autoradiography Methods 0.000 description 3
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 3
238000001574 biopsy Methods 0.000 description 3
230000003915 cell function Effects 0.000 description 3
238000012512 characterization method Methods 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000002596 correlated effect Effects 0.000 description 3
210000004748 cultured cell Anatomy 0.000 description 3
230000037213 diet Effects 0.000 description 3
238000001962 electrophoresis Methods 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
230000001965 increasing effect Effects 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
230000010354 integration Effects 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000011835 investigation Methods 0.000 description 3
239000002502 liposome Substances 0.000 description 3
210000004185 liver Anatomy 0.000 description 3
230000004807 localization Effects 0.000 description 3
230000001404 mediated effect Effects 0.000 description 3
230000011987 methylation Effects 0.000 description 3
238000007069 methylation reaction Methods 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
238000010172 mouse model Methods 0.000 description 3
238000002703 mutagenesis Methods 0.000 description 3
231100000350 mutagenesis Toxicity 0.000 description 3
230000000869 mutational effect Effects 0.000 description 3
230000007170 pathology Effects 0.000 description 3
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 3
230000008488 polyadenylation Effects 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
238000011160 research Methods 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
230000007017 scission Effects 0.000 description 3
239000000243 solution Substances 0.000 description 3
210000001082 somatic cell Anatomy 0.000 description 3
230000000392 somatic effect Effects 0.000 description 3
241000894007 species Species 0.000 description 3
230000000638 stimulation Effects 0.000 description 3
239000000758 substrate Substances 0.000 description 3
230000009469 supplementation Effects 0.000 description 3
229940124597 therapeutic agent Drugs 0.000 description 3
210000003437 trachea Anatomy 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
238000011144 upstream manufacturing Methods 0.000 description 3
238000005406 washing Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
239000005695 Ammonium acetate Substances 0.000 description 2
241000282693 Cercopithecidae Species 0.000 description 2
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
229920000742 Cotton Polymers 0.000 description 2
206010011766 Cystic fibrosis pancreatic Diseases 0.000 description 2
241000702421 Dependoparvovirus Species 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
102000003960 Ligases Human genes 0.000 description 2
108090000364 Ligases Proteins 0.000 description 2
241001045988 Neogene Species 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
238000010222 PCR analysis Methods 0.000 description 2
102000052575 Proto-Oncogene Human genes 0.000 description 2
108700020978 Proto-Oncogene Proteins 0.000 description 2
239000013614 RNA sample Substances 0.000 description 2
206010038997 Retroviral infections Diseases 0.000 description 2
102000006382 Ribonucleases Human genes 0.000 description 2
108010083644 Ribonucleases Proteins 0.000 description 2
108010052164 Sodium Channels Proteins 0.000 description 2
102000018674 Sodium Channels Human genes 0.000 description 2
108010006785 Taq Polymerase Proteins 0.000 description 2
108700019146 Transgenes Proteins 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
241000251539 Vertebrata <Metazoa> Species 0.000 description 2
230000005856 abnormality Effects 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000004913 activation Effects 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
229940043376 ammonium acetate Drugs 0.000 description 2
235000019257 ammonium acetate Nutrition 0.000 description 2
210000004381 amniotic fluid Anatomy 0.000 description 2
230000003466 anti-cipated effect Effects 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
238000011888 autopsy Methods 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
238000004422 calculation algorithm Methods 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
210000004252 chorionic villi Anatomy 0.000 description 2
238000012790 confirmation Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
238000012937 correction Methods 0.000 description 2
230000002380 cytological effect Effects 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000009826 distribution Methods 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000001976 enzyme digestion Methods 0.000 description 2
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
229960005542 ethidium bromide Drugs 0.000 description 2
238000002825 functional assay Methods 0.000 description 2
238000002169 hydrotherapy Methods 0.000 description 2
230000016784 immunoglobulin production Effects 0.000 description 2
238000001114 immunoprecipitation Methods 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
238000002372 labelling Methods 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
230000033001 locomotion Effects 0.000 description 2
230000007774 longterm Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
239000002609 medium Substances 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
238000000386 microscopy Methods 0.000 description 2
230000036457 multidrug resistance Effects 0.000 description 2
210000002850 nasal mucosa Anatomy 0.000 description 2
101150091879 neo gene Proteins 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
239000008188 pellet Substances 0.000 description 2
230000004481 post-translational protein modification Effects 0.000 description 2
230000037452 priming Effects 0.000 description 2
230000004853 protein function Effects 0.000 description 2
210000001938 protoplast Anatomy 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000009711 regulatory function Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
210000002345 respiratory system Anatomy 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
238000010186 staining Methods 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
238000013519 translation Methods 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
241001529453 unidentified herpesvirus Species 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
108020004463 18S ribosomal RNA Chemical group 0.000 description 1
OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 1
LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 1
108020005065 3' Flanking Region Proteins 0.000 description 1
108020005029 5' Flanking Region Proteins 0.000 description 1
ITZMJCSORYKOSI-AJNGGQMLSA-N APGPR Enterostatin Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CCC1 ITZMJCSORYKOSI-AJNGGQMLSA-N 0.000 description 1
108091006112 ATPases Proteins 0.000 description 1
102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
244000307697 Agrimonia eupatoria Species 0.000 description 1
235000016626 Agrimonia eupatoria Nutrition 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
108700003860 Bacterial Genes Proteins 0.000 description 1
241000701822 Bovine papillomavirus Species 0.000 description 1
241001598984 Bromius obscurus Species 0.000 description 1
101150029409 CFTR gene Proteins 0.000 description 1
101710167917 Carbonic anhydrase 2 Proteins 0.000 description 1
102100024633 Carbonic anhydrase 2 Human genes 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108091005462 Cation channels Proteins 0.000 description 1
102000034573 Channels Human genes 0.000 description 1
108700031407 Chloroplast Genes Proteins 0.000 description 1
208000031639 Chromosome Deletion Diseases 0.000 description 1
241000709687 Coxsackievirus Species 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
238000007399 DNA isolation Methods 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
102000001301 EGF receptor Human genes 0.000 description 1
108060006698 EGF receptor Proteins 0.000 description 1
241001466953 Echovirus Species 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
102000005915 GABA Receptors Human genes 0.000 description 1
108010005551 GABA Receptors Proteins 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
206010064571 Gene mutation Diseases 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108010006464 Hemolysin Proteins Proteins 0.000 description 1
208000028782 Hereditary disease Diseases 0.000 description 1
101000573199 Homo sapiens Protein PML Proteins 0.000 description 1
101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
102000003746 Insulin Receptor Human genes 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
208000019693 Lung disease Diseases 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
108091027974 Mature messenger RNA Proteins 0.000 description 1
208000024556 Mendelian disease Diseases 0.000 description 1
208000036626 Mental retardation Diseases 0.000 description 1
241000713333 Mouse mammary tumor virus Species 0.000 description 1
101000907767 Mus musculus Cystic fibrosis transmembrane conductance regulator Proteins 0.000 description 1
230000004988 N-glycosylation Effects 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
208000016222 Pancreatic disease Diseases 0.000 description 1
108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 1
102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 1
201000011252 Phenylketonuria Diseases 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
108091036407 Polyadenylation Proteins 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
101100316117 Rattus norvegicus Unc50 gene Proteins 0.000 description 1
241000725643 Respiratory syncytial virus Species 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
241000282887 Suidae Species 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
101150003725 TK gene Proteins 0.000 description 1
241000011102 Thera Species 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
102000004357 Transferases Human genes 0.000 description 1
108090000992 Transferases Proteins 0.000 description 1
IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
241000700618 Vaccinia virus Species 0.000 description 1
229930003779 Vitamin B12 Natural products 0.000 description 1
241000269370 Xenopus <genus> Species 0.000 description 1
241000269368 Xenopus laevis Species 0.000 description 1
HDRRAMINWIWTNU-NTSWFWBYSA-N [[(2s,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HDRRAMINWIWTNU-NTSWFWBYSA-N 0.000 description 1
ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
108060000200 adenylate cyclase Proteins 0.000 description 1
102000030621 adenylate cyclase Human genes 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
210000001552 airway epithelial cell Anatomy 0.000 description 1
230000004057 allelic distribution Effects 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000009697 arginine Nutrition 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
230000037429 base substitution Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
230000008238 biochemical pathway Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000002459 blastocyst Anatomy 0.000 description 1
230000001680 brushing effect Effects 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
125000000837 carbohydrate group Chemical group 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
210000004671 cell-free system Anatomy 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000014107 chromosome localization Effects 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
239000002131 composite material Substances 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000007906 compression Methods 0.000 description 1
108091036078 conserved sequence Proteins 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000002577 cryoprotective agent Substances 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
229940095074 cyclic amp Drugs 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
URGJWIFLBWJRMF-JGVFFNPUSA-N ddTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 URGJWIFLBWJRMF-JGVFFNPUSA-N 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
239000007857 degradation product Substances 0.000 description 1
238000003936 denaturing gel electrophoresis Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
235000001434 dietary modification Nutrition 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000002224 dissection Methods 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
230000004720 fertilization Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
238000005558 fluorometry Methods 0.000 description 1
230000004907 flux Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
238000010230 functional analysis Methods 0.000 description 1
230000007849 functional defect Effects 0.000 description 1
IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
229960002963 ganciclovir Drugs 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
238000012215 gene cloning Methods 0.000 description 1
230000004545 gene duplication Effects 0.000 description 1
238000012252 genetic analysis Methods 0.000 description 1
238000010448 genetic screening Methods 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
239000011544 gradient gel Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
108060003552 hemocyanin Proteins 0.000 description 1
239000003228 hemolysin Substances 0.000 description 1
108010005397 hemolysin B Proteins 0.000 description 1
208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
235000014304 histidine Nutrition 0.000 description 1
102000054896 human PML Human genes 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
238000003119 immunoblot Methods 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000000415 inactivating effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
238000007689 inspection Methods 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
238000003973 irrigation Methods 0.000 description 1
230000002262 irrigation Effects 0.000 description 1
238000005304 joining Methods 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
235000018977 lysine Nutrition 0.000 description 1
230000002101 lytic effect Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
108020004084 membrane receptors Proteins 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000007102 metabolic function Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
238000001531 micro-dissection Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
208000016366 nasal cavity polyp Diseases 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
102000026415 nucleotide binding proteins Human genes 0.000 description 1
108091014756 nucleotide binding proteins Proteins 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
208000003154 papilloma Diseases 0.000 description 1
210000003681 parotid gland Anatomy 0.000 description 1
230000008775 paternal effect Effects 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
210000004303 peritoneum Anatomy 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000000049 pigment Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
239000000700 radioactive tracer Substances 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000008844 regulatory mechanism Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
238000009256 replacement therapy Methods 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
210000001533 respiratory mucosa Anatomy 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
238000004513 sizing Methods 0.000 description 1
238000007390 skin biopsy Methods 0.000 description 1
210000001626 skin fibroblast Anatomy 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
229940063673 spermidine Drugs 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
239000012089 stop solution Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
230000008685 targeting Effects 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
JOPDZQBPOWAEHC-UHFFFAOYSA-H tristrontium;diphosphate Chemical compound [Sr+2].[Sr+2].[Sr+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O JOPDZQBPOWAEHC-UHFFFAOYSA-H 0.000 description 1
230000010415 tropism Effects 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
239000004474 valine Substances 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
239000011715 vitamin B12 Substances 0.000 description 1
235000019163 vitamin B12 Nutrition 0.000 description 1

Landscapes

Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA 2007699 1990-01-10 1990-01-12 Introns et exons du gene de la fibrose kystique et une mutation a 1507 du gene Abandoned CA2007699A1 (fr)

Priority Applications (8)

Application Number	Priority Date	Filing Date	Title
CA 2007699 CA2007699A1 (fr)	1990-01-12	1990-01-12	Introns et exons du gene de la fibrose kystique et une mutation a 1507 du gene
DE69132616T DE69132616T2 (de)	1990-01-12	1991-01-11	Introns und exons des gens für cystische fibrose sowie mutationen an mehreren stellen des gens
CA002073441A CA2073441C (fr)	1990-01-12	1991-01-11	Introns et exons du gene de la fibrose kystique et mutations a diverses positions du gene
US07/890,609 US6001588A (en)	1990-01-10	1991-01-11	Introns and exons of the cystic fibrosis gene and mutations thereof
AU70605/91A AU7060591A (en)	1990-01-12	1991-01-11	Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene
EP91902210A EP0667900B1 (fr)	1990-01-12	1991-01-11	Introns et exons du gene de la fibrose cystique et mutations a differentes positions du gene
PCT/CA1991/000009 WO1991010734A1 (fr)	1990-01-12	1991-01-11	Introns et exons du gene de la fibrose cystique et mutations a differentes positions du gene
US08/469,461 US5981178A (en)	1990-01-10	1995-06-06	Methods for screening for mutations at various positions in the introns and exons of the cystic fibrosis gene

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA 2007699 CA2007699A1 (fr)	1990-01-12	1990-01-12	Introns et exons du gene de la fibrose kystique et une mutation a 1507 du gene

Publications (1)

Publication Number	Publication Date
CA2007699A1 true CA2007699A1 (fr)	1991-07-12

Family

ID=4144012

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2007699 Abandoned CA2007699A1 (fr)	1990-01-10	1990-01-12	Introns et exons du gene de la fibrose kystique et une mutation a 1507 du gene

Country Status (1)

Country	Link
CA (1)	CA2007699A1 (fr)

1990
- 1990-01-12 CA CA 2007699 patent/CA2007699A1/fr not_active Abandoned

Legal Events

Date	Code	Title	Description
1992-07-12	FZDE	Dead

Publication	Publication Date	Title
EP0667900B1 (fr)	2001-05-23	Introns et exons du gene de la fibrose cystique et mutations a differentes positions du gene
EP0489058B1 (fr)	2003-11-05	Gene de la fibrose cystique
US6984487B1 (en)	2006-01-10	Cystic fibrosis gene
IE83911B1 (en)		Cystic fibrosis gene
US7846679B2 (en)	2010-12-07	Methods for detecting the presence of mutant mammalian presenilin protein
US7534565B2 (en)	2009-05-19	DLC-1 gene deleted in cancers
JP2007312783A (ja)	2007-12-06	Ｄｎａミスマッチ修復経路における変化の検出方法
AU1169492A (en)	1992-08-27	Test and model for alzheimer's disease
JP3449419B2 (ja)	2003-09-22	ＫＶＬＱＴ１をコードするＱＴ延長症候群遺伝子およびそのｍｉｎＫとの関連
US6998467B1 (en)	2006-02-14	Antibody specific for presenilin 1 and method of use thereof
AU647408C (en)	1995-04-06	Cystic fibrosis gene
CA2020817C (fr)	2002-01-01	Introns et exons du gene de la fibrose kystique et mutations a diverses positions du gene
CA2314677A1 (fr)	1999-07-29	Genes associes a l'asthme
JP2000509255A (ja)	2000-07-25	感覚神経障害と関連した遺伝子ファミリー
CA2073441C (fr)	2002-09-10	Introns et exons du gene de la fibrose kystique et mutations a diverses positions du gene
CA2011253A1 (fr)	1991-09-01	Introns et exons du gene de la fibrose kystique et mutations a differentes positions du gene
WO2000011157A9 (fr)	2000-08-17	Dysferline, gene mute dans la myopathie distale et la myopathie des ceintures
WO2000011016A1 (fr)	2000-03-02	Mutations dysferlines
JPH10505742A (ja)	1998-06-09	１７ｑ−連鎖乳癌および卵巣癌感受性遺伝子
JP2004081001A (ja)	2004-03-18	Ｘ染色体連鎖性滑脳症に関連するＡｒｘ遺伝子の変異の検査方法